Your browser doesn't support javascript.
loading
Impact of injection frequency on 5-year real-world visual acuity outcomes of aflibercept therapy for neovascular age-related macular degeneration.
Chandra, Shruti; Rasheed, Rajna; Menon, Deepthy; Patrao, Namritha; Lamin, Ali; Gurudas, Sarega; Balaskas, Konstantinos; Patel, Praveen J; Ali, Naser; Sivaprasad, Sobha.
Afiliação
  • Chandra S; National Institute of Health Research Moorfields Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK. shruti.chandra@nhs.net.
  • Rasheed R; National Institute of Health Research Moorfields Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
  • Menon D; National Institute of Health Research Moorfields Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
  • Patrao N; National Institute of Health Research Moorfields Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
  • Lamin A; National Institute of Health Research Moorfields Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
  • Gurudas S; National Institute of Health Research Moorfields Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
  • Balaskas K; National Institute of Health Research Moorfields Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
  • Patel PJ; National Institute of Health Research Moorfields Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
  • Ali N; National Institute of Health Research Moorfields Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
  • Sivaprasad S; National Institute of Health Research Moorfields Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
Eye (Lond) ; 35(2): 409-417, 2021 02.
Article em En | MEDLINE | ID: mdl-32265509

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Angiogênese / Degeneração Macular Exsudativa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Angiogênese / Degeneração Macular Exsudativa Idioma: En Ano de publicação: 2021 Tipo de documento: Article